Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis - Quiz - MDSpire

Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis

  • By

  • Mark Ebell

  • Peter Kurotschka

  • May 12, 2026

  • 0 min

Share

Original Source(s)

Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis

  • by Mark Ebell, Peter Kurotschka

  • May 12, 2026

Related Content

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis

Analysis of the epidemic situation of respiratory pathogens in central and southern China before and after the COVID-19 pandemic

Hantavirus Outbreak Revives COVID-Era False Health Claims — The Monitor